Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.75−0.18 (-0.64%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Zenas BioPharma total assets
Total assets on the balance sheet at the end of each period.
Zenas BioPharma's total assets was $675.22M at Sep 30, 2026. For fiscal 2025 it was $383.64M, up 3.7% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $383.64M | +3.7% |
| FY2024 | Dec 31, 2024 | $369.97M | +442.6% |
| FY2023 | Dec 31, 2023 | $68.18M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $675.22M | +109.7% |
| Q2 FY2026 | Jun 30, 2026 | $701.69M | +139.4% |
| Q1 FY2026 | Mar 31, 2026 | $747.68M | +124.0% |
| Q4 FY2025 | Dec 31, 2025 | $383.64M | +3.7% |
| Q3 FY2025 | Sep 30, 2025 | $322.02M | -20.2% |
| Q2 FY2025 | Jun 30, 2025 | $293.09M | +329.9% |
| Q1 FY2025 | Mar 31, 2025 | $333.77M | – |
| Q4 FY2024 | Dec 31, 2024 | $369.97M | – |
| Q3 FY2024 | Sep 30, 2024 | $403.43M | – |
| Q4 FY2023 | Dec 31, 2023 | $68.18M | – |
See a number that looks wrong?